Viewpoint Molecular Recieves $2M in SBIR Funding

October 17, 2017

Viewpoint Molecular Targeting LLC., based at the UI BioVentues Center in Coralville, was awarded a PHase II Small Business Innovation Reserach (SBIR) contract.

Viewpoint Molecular Targeting, LLC, Coralville

January 2, 2018

Mike Schultz and Frances Johnson are looking to bring the number of metastatic melanoma patients down. Based on discoveries in the lab, the duo started Viewpoint Molecular Targeting, LLC, a company based around a revolutionary radio-pharmaceutical to improve those odds.